The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK
SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...
Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone
The US Food and Drug Administration (FDA) has granted accelerated approval to Talon Therapeutics' Marqibo (vinCRIStine sulfate LIPOSOME injection). Marqibo, a sphingomyelin/cholesterol liposome-encapsulated formulation of vincristine ...
European Medicines Agency (EMA) has accepted to review Pfizer's marketing authorization application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE). BZA/CE is designed for postmenopausal women with a uterus for the treatment of ...
Tags: bazedoxifene conjugated estrogens, BZA/CE, estrogen deficiency symptoms
The Street Fair is grandest show of the year for the Bais. Held from the 15th day to the 21st day of the third lunar month every year at the foot of the Mount Diancang Shan, west to the ancient city of Dali, the Bais are holding the ...
Tags: Street Fair, good harvest, Harvest, traditional commodities
Eisai has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for Fycompa (perampanel), an AMPA receptor antagonist. Fycompa (perampanel) is an adjunctive treatment of ...
Tags: fycompa, perampanel, epilepsy, zonisamide
As a sort of demolded clay figurines exclusively made in Tibet, "Tsha-Tsha" is mainly small stupa and joss, which was the Buddhist artwork introduced from ancient India. Being a halidom used to express devout belief to Buddha and pray for ...
Gilead Sciences has received US Food and Drug Administration (FDA) approval for Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Stribild is a complete once-daily single tablet ...
Janssen-Cilag International has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval to use the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as ...
Tags: investigational drug bedaquiline, multi-drug resistant tuberculosis
Janssen Biotech and Janssen Biologics have submitted a supplemental biologics license application (sBLA) to the US Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) seeking approval of Simponi ...
Tags: Simponi, golimumab, active ulcerative colitis, anti-tumor necrosis factor
Food Standards Australia New Zealand (FSANZ) has issued a warning about supplementary sports foods containing an ingredient known as DMAA, following some adverse health reports in Australia. FSANZ Deputy chief executive officer Melanie ...
Tags: adverse health reports, warning about supplementary sports foods
The Therapeutic Goods Administration (TGA), the regulatory body for therapeutic goods in Australia, has prohibited sale, supply and use of DMAA (1,3-dimethylamylamine), an ingredient used in some sports supplements. The TGA noted that it ...
Tags: therapeutic goods, sports supplements, reports of adverse effects
Mozambica has opened an anti-retroviral(ARV) drugs manufacturing factory, Maputo, in the southern Matola. The Brazil funded plant will initially package, store and distribute the anti-retroviral drug, Nevirapine.produce Nevirapine, which ...
Tags: ARV drugs, anti retroviral drug, Mozambica
Pfizer has won US FDA approval for its rheumatoid arthritis (RA) therapy, Xeljanz (tofacitinib citrate) 5mg twice daily, indicated for patients who failed to respond to methotrexate. Xeljanz can be used as a single treatment regime or as ...
Tags: Pfizer, tofacitinib citrate, Xeljanz
Sosei Group Corporation,Japan, has received a positive opinion for its Seebri Breezhaler (glycopyrronium bromide/NVA237),a type of bronchodilator, from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). ...
Tags: Seebri Breezhaler, bronchodilator, CHMP, Positive Chmp Opinion